Cancer Treatment Centers of America Join Pacira Pharmaceuticals in Opioid Risk Reduction Initiative

In Markets Insider’s recent article provided by PR Newswire called “Cancer Treatment Centers of America Teams with Pacira Pharmaceuticals, Inc. on Innovative Collaboration to Educate Physicians and Patients about Responsible Opiod Use”, which discusses the Opioid Risk Reduction Initiative.The Opioid Risk Reduction Initiative is the brainchild of Pacira Pharmaceuticals, Inc. and Cancer Treatment Centers of America. The purpose of the initiative is to spread awareness of opioid alternatives through education, likewise improving cancer patients’ experience by providing different pain management options. Cancer Treatment Centers of America’s Chief of the Division of Anesthesia, Neil Seeley, reveals that narcotics have been the base of treating the cancer patient’s pain. However, with the help of Pacira, they began to recognize the risks of narcotics while also recognizing alternatives for pain control.

The education begins with helping physicians understand the alternative. In a national survey, more than 91% of the doctors felt pressure to prescribe narcotics and opioids for their patients, and often more than the patients need.The Opioid Risk Initiative seeks to accomplish three major goals. First, they hope to educate patients experiencing the harsh effects of cancer and treatment about the alternative pain relief options. The patients need to understand the alternatives to opioids and how to use opioids responsibly. After all, in a survey titled “Opioid Addiction and Dependence After Surgery is Significantly Higher than Previously Known”, it was revealed that many clinicians provide opioids to help their patients manage pain after surgery.

Second, the initiative is supposed to educate the medical community on opioid alternatives. Lastly, they seek to provide clinical standardization on evidence based non-opioid pain management procedures.Cancer Treatment Centers of America is a network of five hospitals across the United States. They have locations in Florida, Illinois, Oklahoma, Pennsylvania, Arizona, and Georgia. They have earned recognition by a variety of leading health care organizations and have earned numerous awards like the Top Performer on Key Quality Measures and Magnet Award.Cancer Treatment Centers of America use the latest treatment approaches and technology to provide patients with the latest therapy and medications available.

Eric Lefkofsky Has a Personal Stake in His Latest Venture

Eric Lefkofsky was at a stage of his career that was beyond the starting of new companies when he created Tempus in 2016. However, this venture was different from those of the past. Tempus was established for the specific purpose helping cancer patients, among whom is his wife Elizabeth.

Based in Chicago, Tempus is a high-tech company that uses the latest data to fight cancer. Working in conjunction with a number of health related organizations, including the Mayo Clinic and the University of Chicago, Tempus employs an automated analyzing technique to study various forms of cancer. Using the information provided, doctors can determine the type of cancer that has developed in their patients and create a personalized treatment plan in each case. The company has expanded rapidly and presently employs some 150 personnel, some of whom are medical doctors.

The 47-year-old Lefkofsky launched Tempus with the help of long-time business partner Brad Keywell. Reportedly possessing a net worth of nearly $2 billion, Lefkofsky said he is willing to continue investing his own money to ensure that the company remains operational. Fighting cancer became a personal issue for Lefkofsky after his wife Elizabeth was diagnosed with the disease.

Accompanying Elizabeth the many times she sought treatment, Lefkofsky saw first-hand the confusion and frustration that is often experienced cancer patients and the health professionals who care for them. He often found that the technology used to provide cancer information to doctors was inferior to that used in providing data to truck drivers. Lefkofsky admitted that the goals of Tempus are long-term in nature, but the data that has been collected could eventually help save lives.

Tempus is only the latest venture for Lefkofsky, who also helped establish such media and information-related companies as Groupon, InnerWorkings and Lightbank. In 2006, he and his wife created the Lefkofsky Family Foundation, a charitable organization designed to benefit citizens in a number of ways.

A graduate of the University of Michigan Law School, Lefkofsky serves as an adjunct professor at the University of Chicago. His commitment to the community is displayed by his financial support of some local institutions, including Lurie Children’s Hospital, The Art Institute of Chicago and the Museum of Science and Industry.